Uncategorized BiomX reports “impressive” data in first bacteriophage trial 25 Feb 2023 Hope that bacteriophages could represent a new therapeutic strategy for resistant bacterial infections has been bolstered by a study conducted by BiomX in cystic fibrosis (CF) patients. While still early,…